Research programme: serotonin reuptake inhibitors - PfizerAlternative Names: UK-373911
Latest Information Update: 05 Aug 2009
At a glance
- Originator Pfizer
- Mechanism of Action Adrenergic receptor antagonists; Serotonin uptake inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Major depressive disorder; Stress incontinence
Most Recent Events
- 05 Aug 2009 No development reported - Preclinical for Stress incontinence in United Kingdom (unspecified route)
- 05 Aug 2009 No development reported - Preclinical for Depression in United Kingdom (unspecified route)